1. Innate-like T cells in liver disease.
- Author
-
Yang, Albert Ying-Po, Wistuba-Hamprecht, Kilian, Greten, Tim F., and Ruf, Benjamin
- Subjects
- *
T cells , *LIVER cells , *LIVER diseases , *NON-alcoholic fatty liver disease , *HEPATITIS , *FATTY liver - Abstract
Mammalian innate-like T cells (ILTCs), including natural killer T (NKT), mucosal-associated invariant T (MAIT), and γδ T cells are tissue-resident unconventional T cells that share properties of innate and adaptive immunity. ILTC subsets can secrete cytotoxic effector molecules and cytokines to clear out abnormal hepatocytes, initiate effector cell recruitment and inflammation, and contribute to regulating homeostasis and tissue regeneration in liver diseases. ILTCs can contribute to both protective and pathogenic functions depending on the liver disease stage and tissue context. ILTCs can contribute to liver inflammation and injury in different pathological conditions including viral hepatitis, alcoholic liver disease, non-alcoholic fatty liver disease (NAFLD), cirrhosis, and others. Targeting ILTCs or modulating their functions may represent potential therapeutic strategies to help to treat liver diseases by aiming to restore immune balance and mitigating liver inflammation. As abundant tissue-resident lymphocytes, ILTCs play important roles in ensuring liver tissue integrity during homeostasis, infection, and non-infectious chronic perturbations. Pathological conditions, including viral infections, metabolic dysfunction, alcohol consumption, and others, can significantly influence the phenotype and function of ILTCs, further underscoring their dynamic role in liver immune responses across different disease contexts. Understanding the intricate interplay between ILTCs, other cells, and niches in liver diseases is essential for developing targeted therapeutic interventions to restore immune balance and mitigate pathology. Mammalian innate-like T cells (ILTCs), including mucosal-associated invariant T (MAIT), natural killer T (NKT), and γδ T cells, are abundant tissue-resident lymphocytes that have recently emerged as orchestrators of hepatic inflammation, tissue repair, and immune homeostasis. This review explores the involvement of different ILTC subsets in liver diseases. We explore the mechanisms underlying the pro- and anti-inflammatory effector functions of ILTCs in a context-dependent manner. We highlight latest findings regarding the dynamic interplay between ILTC functional subsets and other immune and parenchymal cells which may inform candidate immunomodulatory strategies to achieve improved clinical outcomes in liver diseases. We present new insights into how distinct gene expression programs in hepatic ILTCs are induced, maintained, and reprogrammed in a context- and disease stage-dependent manner. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF